I can’t remember seeing so many company announcements so fast and furious as the last few weeks. Must be something in the air this fall. This announcement just came out today.

Boehringer Ingelheim Vetmedica, Inc. has decided to sell its antimicrobial brand Denagard® (tiamulin) to Novartis Animal Health effective on Oct. 7, 2005. Under the terms of the agreement, Boehringer Ingelheim will continue to manufacture Denagard for Novartis.

That sounds like a good deal. Sell the brand and then get paid to produce the product. Sweet!